Skip to content
AH-130
Tissue
Liver
Disease
Hepatocellular carcinoma
Metastatic site
Ascites
Synonyms
Yoshida AH-130, Yoshida AH130, AH130, AH 130, AH-130 Yoshida, AH130-TC, AH130/P

Documents

AH-130

Cell line · Product number 500412

Yoshida et al. have established the ascites hepatoma by converting the aminoazo dyeinduced hepatoma of the rat into the ascetic form (Yoshida 1956). AH-130 i...

€800.00excl. tax and shipping
In stock
Lot
Recommended (freshest lot)
  • CoA
1

01General information

Description
Yoshida et al. have established the ascites hepatoma by converting the aminoazo dyeinduced hepatoma of the rat into the ascetic form (Yoshida 1956). AH-130 is a strain of ascites hepatoma composed of free tumor cells, only small islands of tumor islets are present. The cell line described here was established as in vitro cell culture from this Yoshida AH-130 strain of ascites hepatoma.
Tissue
Liver
Disease
Hepatocellular carcinoma
Metastatic site
Ascites
Applications
Hepatocellular carcinoma research; rat liver tumor biology; Yoshida ascites hepatoma model; drug sensitivity and cytotoxicity testing; adenovirus susceptibility studies; preclinical liver cancer modeling in Sprague-Dawley rats; adherent/suspension tumor biology
Synonyms
  • Yoshida AH-130
  • Yoshida AH130
  • AH130
  • AH 130
  • AH-130 Yoshida
  • AH130-TC
  • AH130/P

02Classification

Organism
Rat
Sex
Unspecified
Growth properties
Adherent and suspension
GMO status
Non-GMO
GMO status details
No genetic modification; transplantable rat ascites hepatoma derived from aminoazo dye-induced primary hepatoma by Yoshida (1956)
Biosafety level
1

03Characteristics

Morphology
Round suspension cells, triangular adherent cells
Cell type
Hepatocellular carcinoma cells (hepatocarcinoma)
Tumourigenic
Yes, in Wistar and other strains.
Doubling time
approx. 18 to 24 hours (fast growing; BD=Fast confirmed)

04Identifiers

Citation
AH-130 (Cytion catalog number 500412)
NCBI TaxID
10116
Cellosaurus
CVCL_4367

05Expression and susceptibility

Viruses
RAP-test negative. .
Virus susceptibility
Highly sensitive to human adenoviruses

06Handling and culture

Culture medium
DMEM:Ham's F12 (1:1), w: 3.1 g/L Glucose, w: 2.5 mM L-Glutamine, w: 15 mM HEPES, w: 0.5 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
Incubation atmosphere

37°C, 5% CO2, humidified atmosphere.

Supplements
Supplement the medium with 10% FBS
Dissociation reagent
Accutase
Subculturing
Gather the suspension cells in a 15 ml tube and gently wash the adherent cells with PBS lacking calcium and magnesium (use 3-5 ml for T25 flasks and 5-10 ml for T75 flasks). Apply Accutase (1-2 ml for T25 flasks, 2.5 ml for T75 flasks) ensuring full coverage of the cell layer. Allow the cells to incubate at room temperature for 10 minutes. Following incubation, combine and centrifuge both the suspension and adherent cells. After centrifugation, carefully resuspend the cell pellet and transfer the cell suspension into new flasks containing fresh medium.
Split ratio
1 to 3
Seeding density
2 x 104 cells/cm2
Fluid renewal
Every 3 to 5 days
Post-thaw recovery
Fast
Thawing and culturing
  1. Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.

  2. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.

  3. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.

  4. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.

  5. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.

  6. Centrifuge the mixture at 300 x g for 3 minutes to separate the cells and carefully discard the supernatant containing residual freezing medium.

  7. Gently resuspend the cell pellet in 10 ml of fresh culture medium. For adherent cells, divide the suspension between two T25 culture flasks; for suspension cultures, transfer all the medium into one T25 flask to promote effective cell interaction and growth.

  8. Adhere to established subculture protocols for continued growth and maintenance of the cell line, ensuring reliable experimental outcomes.

07Quality control and cryopreservation

Sterility

Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods.

To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections.

Freeze medium
As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress.
Storage conditions

For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.

Shipping conditions

Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.

08Donor

Breed / subspecies
Sprague-Dawley
Donor age
Age unspecified
Ethnicity
Not applicable (rat cell line; Sprague-Dawley in Q)